<bill session="117" type="h" number="6160" updated="2022-12-30T03:04:06Z">
  <state datetime="2021-12-07">REFERRED</state>
  <status>
    <introduced datetime="2021-12-07"/>
  </status>
  <introduced datetime="2021-12-07"/>
  <titles>
    <title type="display">Access to Rare Indications Act of 2021</title>
    <title type="short" as="introduced">Access to Rare Indications Act of 2021</title>
    <title type="official" as="introduced">To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to provide for coverage of certain drugs used in the treatment or management of a rare disease or condition, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001163"/>
  <cosponsors>
    <cosponsor bioguide_id="E000296" joined="2022-10-07"/>
    <cosponsor bioguide_id="F000466" joined="2022-02-18"/>
    <cosponsor bioguide_id="K000376" joined="2021-12-07"/>
    <cosponsor bioguide_id="M001190" joined="2021-12-07"/>
    <cosponsor bioguide_id="S001207" joined="2022-11-29"/>
    <cosponsor bioguide_id="S001218" joined="2022-07-07"/>
    <cosponsor bioguide_id="T000460" joined="2021-12-07"/>
  </cosponsors>
  <actions>
    <action datetime="2021-12-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-12-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-12-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-12-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-05-06T14:11:28Z" status="Introduced in House">Access to Rare Indications Act of 2021

This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.</summary>
</bill>
